The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early detection for pancreatic cancer in individuals at elevated-risk, using endoscopic ultrasound (EUS) and magnetic resonance imaging (MRI) of the abdomen: Feasibility and preliminary outcomes.
 
Joshua P. Raff
Stock and Other Ownership Interests - Genentech
 
Charles Noyer
No Relationships to Disclose
 
Nicole Boxer
No Relationships to Disclose
 
Sara Sadan
No Relationships to Disclose
 
Dan Costin
No Relationships to Disclose
 
Sasan Roayaie
Consulting or Advisory Role - Medtronic
Travel, Accommodations, Expenses - Medtronic
 
Mark Gordon
No Relationships to Disclose
 
Meghan Kaumaya
No Relationships to Disclose
 
Una Hopkins
Speakers' Bureau - AstraZeneca; Eisai
Travel, Accommodations, Expenses - Association of Community Cancer Centers (ACCC)
 
Marisa Cortese
No Relationships to Disclose
 
Melissa Rowan Rice
No Relationships to Disclose
 
Sanjay Goel
Research Funding - BeiGene (Inst); Oncolytics (Inst)
Patents, Royalties, Other Intellectual Property - I have a patent with a co-inventor, John Mariadason, Ph.D, entitled "Method Of Determining The Sensitivity Of Cancer Cells To EGFR Inhibitors Including Cetuximab, Panitumumab And Erlotinib.", Patent No. 20090258364